SXTP | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

13.79%

1 Month

30.69%

3 Months

6.49%

6 Months

388.89%

1 Year

14.29%

2 Year

-71.79%

Key data

Stock price

$1.36

P/E Ratio

0.00

DAY RANGE

$1.30 - $1.32

EPS

$0.00

52 WEEK RANGE

$0.10 - $2.54

52 WEEK CHANGE

$18.92

MARKET CAP

2.370 M

YIELD

N/A

SHARES OUTSTANDING

1.768 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

-0.46

PUBLIC FLOAT

AVERAGE 10 VOLUME

$402,649

AVERAGE 30 VOLUME

$794,006

Company detail

CEO: Geoffrey Dow
Region: US
Website: 60degreespharma.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

We are a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Our principal executive offices are located at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C.

SXTP - 60 DEGREES PHARMACEUTICALS, INC.